A novel lipoprotein (a) lowering drug, D-47, decreases neointima thickening after vascular injury
-
- Nakaya Yutaka
- Department of Nutrition and Metabolism, Institute of Biomedical sciences, Tokushima University Graduate School
-
- Fukuda Daiju
- Department of Cardiology, Institute of Biomedical sciences, Tokushima University Graduate School
-
- Oyamada Takashi
- Department of Nutrition and Metabolism, Institute of Biomedical sciences, Tokushima University Graduate School
-
- Ogawa Kazuo
- Pharmaceutical Science, Tokushima Bunri University
-
- Harada Nagakatsu
- Department of Nutrition and Metabolism, Institute of Biomedical sciences, Tokushima University Graduate School
-
- Nakagami Hironori
- Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University
-
- Morishita Ryuichi
- Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University
-
- Sata Masataka
- Department of Cardiology, Institute of Biomedical sciences, Tokushima University Graduate School
-
- Sakaue Hiroshi
- Department of Nutrition and Metabolism, Institute of Biomedical sciences, Tokushima University Graduate School
Search this article
Abstract
<p>Although Lp(a) have been thought to be a cardiovascular risk factor, it is unclear whether lowering Lp(a) levels reduces the risk of cardiovascular diseases. No pharmacological agents which selectively reduce serum Lp(a) levels, and Lp(a) is present in primate but absent in common laboratory animals such as mice and pigs. In the present study we used transgenic mice of human Lp(a) and tested effect a novel Lp(a) lowering drug D-47 on neointima formation after vascular injury. D-47 successfully decreased plasma levels of Lp(a) and possibly inhibited neointima formation in Lp(a) transgenic mice. The results indicate that we can modulate plasma Lp(a) levels by pharmacologic agents and inhibit atherogenic properties of Lp(a) by reducing plasma levels of Lp(a). J. Med. Invest. 64: 64-67, February, 2017</p>
Journal
-
- The Journal of Medical Investigation
-
The Journal of Medical Investigation 64 (1.2), 64-67, 2017
The University of Tokushima Faculty of Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204245513344
-
- NII Article ID
- 130005501982
-
- NII Book ID
- AA11166929
-
- ISSN
- 13496867
- 13431420
-
- PubMed
- 28373630
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed